TP53 and breast cancer: Our observation of separate cell cycle modules in luminal breast cancers dependent on TP53 status suggests that luminal tumors can be further stratified independently of proliferation, and supports a picture in which defective cell cycle checkpoints do not always correspond to high proliferative rates in breast cancers [10].